Increased serum sFas and TNFα following isolated severe head injury in males

References

• Bruns JRJ, Hauser WA. The epidemiology of traumatic brain injury: A review. Epilepsia 2003; 44: 2–10
   PubMed Web of Science ®Google Scholar
• Kraus JF, Macarthur DL, Silverman TA, Jayaraman M. Epidemiology of brain injury. Neurotrauma, RK Narayan, JE Wilberger, Jr, JT Povlishock. McGraw-Hill, New York 1996; 13–30
   Google Scholar
• Wilson JTL, Pettigrew LEL, Teasdale GM. Structured interviews for the glasgow outcome scale and the extended glasgow outcome scale: Guidelines for their use. Journal of Neurotrauma 1998; 15: 573–585
   PubMed Web of Science ®Google Scholar
• Faden AI. Neuroprotection and traumatic brain injury: Theoretical option or realistic proposition. Current Opinion in Neurology 2002; 15: 707–712
   PubMed Web of Science ®Google Scholar
• Duff D. Altered states of consciousness, theories of recovery and assessment following a severe traumatic brain injury. Axone 2003; 23: 18–23
   Google Scholar
• Faden AI, Demediuk P, Panter SS, Vink R. The role of excitatory amino acids and NMDA receptors in traumatic brain injury. Science 1989; 244(4906)798–800
   PubMed Web of Science ®Google Scholar
• Ghajar J. Traumatic brain injury. Lancet 2000; 356: 923–929
   PubMed Web of Science ®Google Scholar
• Lenzlinger PM, Marx A, Trentz O, Kossmann T, Morganti-Kossmann MC. Prolonged intrathecal release of soluble Fas following severe traumatic brain injury in humans. Journal of Neuroimmunology 2002; 22: 167–174
   Google Scholar
• Qiu J, Whalen MJ, Lowenstein P, Fiskum G, Fahy B, Darwish R, Aarabi B, Yuan J, Moskowitz MA. Upregulation of the Fas Receptor death-inducing signaling complex after traumatic brain injury in mice and humans. Journal of Neuroscience 2002; 22: 3504–3511
   PubMedGoogle Scholar
• Stoll G, Jander S, Schroeter M. Detrimental and beneficial effects of injury-induced inflammation and cytokine expression in the nervous system. Advances in Experimental Medicine & Biology 2002; 513: 87–113
   PubMedGoogle Scholar
• Colicos MA, Dash PK. Apoptotic morphology of dentate gyrus granule cells following experimental cortical impact injury in rats: Possible role in spatial memory deficits. Brain Research 1996; 730: 120–131
   Google Scholar
• Arends MJ, Wyllie AH. Apoptosis: Mechanisms and roles in pathology. International Review of Experimental Pathology 1991; 32: 223–254
   PubMedGoogle Scholar
• Kanduc D, Mittelman A, Serpico R, Sinigaglia E, Sinha A, Natale C, Santacroce R, Di Corcia MG, Lucchese A, Dini L, et al. Cell death: Apoptosis vs. necrosis (review). International Journal of Oncology 2002; 21: 165–170
   PubMed Web of Science ®Google Scholar
• Bredesen DE. Apoptosis: Overview and signal transduction pathways. Journal of Neurotrauma 2000; 17: 801–810
   PubMed Web of Science ®Google Scholar
• Eldadah BA, Faden AI. Caspase pathways, neuronal apoptosis, and CNS injury. Journal of Neurotrauma 2000; 17: 811–829
   PubMed Web of Science ®Google Scholar
• Zhang X, Graham SH, Kochanek PM, Marion DW, Nathaniel PD, Watkins SC, Clark RS. Caspase-8 expression and proteolysis in human brain after severe head injury. FASEB Journal 2003; 17: 1367–1369
   PubMed Web of Science ®Google Scholar
• Lambert C, Landau AM, Desbarats J. Fas – Beyond death: A regenerative role for Fas in the nervous system. Apoptosis 2003; 8: 551–562
   PubMedGoogle Scholar
• Chen J, Zhou T, Liu C, Shapiro JP, Brauer MJ, Kiefer MC, Barr PJ, Mountz JD. Protection from Fas-mediated apoptosis by a soluble form of the Fas molecule. Science 1994; 263: 1759–1762
   PubMedGoogle Scholar
• Cheema ZF, Wade SB, Walsh K, Sohrabji F, Miranda RC. Fas/APO [apoptosis]-1 and associated proteins in the differentiating cerebral cortex: Induction of caspase-dependent cell death and activation of NF-κB. Journal of Neuroscience 1999; 19: 1754–70
   PubMedGoogle Scholar
• Raoul C, Henderson CE, Pettman B. Programmed cell death of embryonic motoneurons triggered through the Fas death receptor. Journal of Cell Biology 1999; 147: 1049–1062
   PubMedGoogle Scholar
• Raoul C, Pettman B, Henderson CE. Active killing of neurons during development and following stress: A role for p75(NTR) and Fas?. Current Opinion in Neurobiology 2000; 10: 111–117
   PubMedGoogle Scholar
• Felderhoff-Mueser U, Taylor DL, Greenwood K, Kozma M, Stibenz D, Joashi UC, Edwards AD, Mehmet H. Fas/CD95/APO-1 can function as a death receptor for neuronal cells in vitro and in vivo and is upregulated following cerebral hypoxic-ischemic injury to the developing rat brain. Brain Pathology 2000; 10: 17–29
   PubMed Web of Science ®Google Scholar
• Rosebaum DM, Gupta G, D’Amore J, Singh M, Weidenheim K, Zhang H, Kessler JA. Fas (CD95/APO-1) plays a role in the pathophysiology of focal cerebral ischemia. Journal of Neuroscience Research 2000; 61: 686–692
   PubMedGoogle Scholar
• Martin-Vallalba A, Hahne M, Kleber S, Vogel J, Falk W, Schenkel J, Krammer PH. Therapeutic neutralization of CD95-ligand and TNF attenuates brain damage in stroke. Cell Death Difference 2001; 8: 679–686
   PubMedGoogle Scholar
• Roof RL, Hall ED. Gender differences in acute CNS trauma and stroke: Neuroprotective effects of estrogen and progesterone. Journal of Neurotrauma 2000; 17: 367–388
   PubMed Web of Science ®Google Scholar
• Jarrar D, Wang P, Cioffi WG, Bland KI, Chaudry I. The female reproductive cycle is an important variable in the response to trauma-hemorrhage. American Journal of Physiology and Heart Circulation Physiology 2000; 279: H1015–H1021
   PubMed Web of Science ®Google Scholar
• Newcomb JK, Zhao X, Pike BR, Hayes RL. Temporal profile of apoptotic-like changes in neurons and astrocytes following controlled cortical impact injury in the rat. Experimental Neurology 1999; 158: 76–88
   PubMed Web of Science ®Google Scholar
• Clark RS, Kochanek PM, Chen M, Watkins SC, Marion DW, Chen J, Hamilton RL, Loeffert JE, Graham SH. Increases in Bcl-2 and cleavage of caspase-1 and caspase-3 in human brain after head injury. FASEB Journal 1999; 13: 813–821
   PubMed Web of Science ®Google Scholar
• Smith DH, Chen XH, Pierce JE, Wolf JA, Trojanowski JQ, Graham DI, McIntosh TK. Progressive atrophy and neuron death for one year following brain trauma in the rat. Journal of Neurotrauma 1997; 14: 715–727
   PubMed Web of Science ®Google Scholar
• Finfer SR, Cohen J. Severe traumatic brain injury. Resuscitation 2001; 48: 77–90
   PubMed Web of Science ®Google Scholar
• Schmidt OI, Morganti-Kossmann MC, Heyde CE, Perez D, Yatsiv I, Shohami E, Ertel W, Stahel PF. Tumor necrosis factor-mediated inhibition of interleukin-18 in the brain: A clinical and experimental study in head-injured patients and in a murine model of closed head injury. Journal of Neuroinflammation 2004; 1: 13
   PubMed Web of Science ®Google Scholar
• Maier B, Laurer HL, Rose S, Buurman WA, Marzi I. Physiological levels of pro- and anti-inflammatory mediators in cerebrospinal fluid and plasma: A normative study. Journal of Neurotrauma 2005; 22: 822–835
   PubMed Web of Science ®Google Scholar
• Shiozaki T, Hayakata T, Tasaki O, Hosotubo H, Fujita K, Mouri T, Tajima G, Kajino K, Nakae H, Tanaka H, et al. Cerebrospinal fluid concentrations of anti-inflammatory mediators in early-phase severe traumatic brain injury. Shock 2005; 23: 406–410
   PubMed Web of Science ®Google Scholar
• Hengartner MO. The biochemistry of apoptosis. Nature 2000; 407(6805)770–776
   PubMed Web of Science ®Google Scholar
• Chen Y, Swanson RA. Astrocytes and brain injury. Journal of Cerebral Flow Metabolism 2003; 23: 137–149
   PubMed Web of Science ®Google Scholar
• Lai YC, Chen FG, Goh MH, Koh KF. Predictors of long-term outcome in severe head injury. Annals of Academic Medicine of Singapore 1998; 27: 326–331
   PubMedGoogle Scholar
• Herrmann M, Curio N, Jost S, Grubich C, Ebert AD, Fork ML, Synowitz H. Release of biochemical markers of damage to neuronal and glial brain tissue is associated with short and long term neuropsychological outcome after traumatic brain injury. Journal of Neurology, Neurosurgery & Psychiatry 2001; 70: 95–100
   PubMed Web of Science ®Google Scholar
• Regner A, Kaufmann M, Friedman G, Chemale I. Increased serum S100ß protein concentrations following severe head injury in humans: A biochemical marker of brain death?. Neuroreport 2001; 12: 691–694
   PubMed Web of Science ®Google Scholar
• Mussack T, Biberthaler P, Kanz KG, Wiedemann E, Gippner-Steppert C, Mutschler W, Jochum M. Serum S-100B and interleukin-8 as predictive markers for comparative neurologic outcome analysis of patients after cardiac arrest and severe traumatic brain injury. Critical Care Medicine 2002; 30: 2669–2674
   PubMed Web of Science ®Google Scholar
• Raabe A, Kopetsch O, Woszczyk A, Lang J, Gerlach R, Zimmermann M, Seifert V. Serum S100B protein as a molecular marker in severe traumatic brain injury. Restorative Neurology & Neuroscience 2003; 21: 159–169
   PubMed Web of Science ®Google Scholar
• Vos PE, Lamers KJ, Hendriks JC, Van Haaren M, Beems T, Zimmerman C, Van Geel W, De Reus H, Biert J, Verbeek MM. Glial and neuronal proteins in serum predict outcome after severe traumatic brain injury. Neurology 2004; 62: 1303–1310
   PubMed Web of Science ®Google Scholar
• Da Rocha AB, Zanoni C, Freitas GR, André C, Himelfarb S, Schneider RF, Grivicich I, Borges L, Schwartsmann G, Kaufmann M, et al. Serum Hsp70 as an early predictor of fatal outcome after severe traumatic brain injury in males. Journal of Neurotrauma 2005; 22: 966–977
   PubMed Web of Science ®Google Scholar
• Da Rocha AB, Schneider RF, Freitas GR, André C, Grivicich I, Zanoni C, Fossa A, Gehrke JT, Pereira Jotz G, Kaufmann M, et al. Role of serum S100B as a predictive marker of fatal outcome Following isolated severe head injury or multitrauma in males. Clinical Chemistry & Laboratory Medicine 2006; 44: 1234–1242
   PubMed Web of Science ®Google Scholar
• Marshall LF. Head injury: Recent past, present, and future. Neurosurgery 2000; 47: 546–561
   PubMed Web of Science ®Google Scholar
• Quintana A, Giralt M, Rojas S, Penkowa M, Campbell IL, Hidalgo J, Molinero A. Differential role of tumor necrosis factor receptors in mouse brain inflammatory responses in cryolesion brain injury. Journal of Neuroscience Research 2005; 82: 701–716
   PubMed Web of Science ®Google Scholar
• Lotocki G, Alonso OF, Dietrich WD, Keane RW. Tumor necrosis factor receptor 1 and its signaling intermediates are recruited to lipid rafts in the traumatized brain. Journal of Neuroscience 2004; 24(49)11010–11016
   PubMedGoogle Scholar
• Goodman JC, Robertson CS, Grossman RG, Narayan RK. Elevation of tumor necrosis factor in head injury. Journal of Neuroimmunology 1990; 30: 213–217
   PubMed Web of Science ®Google Scholar
• Ross SA, Halliday MI, Campbell GC, Byrnes DP, Rowlands BJ. The presence of tumor necrosis factor in the CSF and plasma after severe head injury. British Journal of Neurosurgery 1994; 8: 419–425
   PubMed Web of Science ®Google Scholar
• Wang CX, Shuaib A. Involvement of inflammatory cytokines in central nervous system injury. Progress in Neurobiology 2002; 67: 161–172
   PubMed Web of Science ®Google Scholar
• Kamm K, Vanderkolk W, Lawrence C, Jonker M, Davis AT. The effect of traumatic brain injury upon the concentration and expression of interleukin-1beta and interleukin-10 in the rat. Journal of Trauma 2006; 60: 152–157
   PubMedGoogle Scholar
• Lenzlinger PM, Morganti-Kossmann MC, Laurer HL, McIntosh TK. The duality of the inflammatory response to traumatic brain injury. Molecular Neurobiology 2001; 24: 169–181
   PubMed Web of Science ®Google Scholar
• Shohami E, Ginis I, Hallenbeck JM. Dual role of tumor necrosis factor alpha in brain injury. Cytokine Growth Factor Review 1999; 10: 119–130
   PubMed Web of Science ®Google Scholar
• Nagata S. Fas ligand-induced apoptosis. Annual Review of Genetics 1999; 33: 29–55
   PubMed Web of Science ®Google Scholar
• Raghupathi R, Graham DI, McIntosh TK. Apoptosis after traumatic brain injury. Journal of Neurotrauma 2000; 17: 927–938
   PubMed Web of Science ®Google Scholar
• Beer R, Franz G, Schopf M, Reindl M, Zelger B, Schmutzhard E, Poewe W, Kampft A. Expression of Fas and Fas ligand after experimental traumatic brains injury in the rat. Journal of Cerebral Blood Flow Metabolism 2000; 20: 429–435
   Google Scholar
• Ertel W, Keel M, Stocker R, Imhof HG, Leist M, Steckholzer U, Tanaka M, Trentz O, Nagata S. Detectable concentrations of Fas ligand in cerebrospinal fluid after severe head injury. Journal of Neuroimmunology 1997; 80: 93–96
   PubMedGoogle Scholar
• Yonehara S, Ishii A, Yonehara M. A cell-killing monoclonal antibody (anti-Fas) to a cell surface antigen co-downregulated with the receptor of tumor necrosis factor. Journal of Experimental Medicine 1989; 169: 1747–1756
   PubMed Web of Science ®Google Scholar
• Itoh N, Yonehara S, Ishii A, Yonehara M, Mizushima S, Samashima M, Hase A, Seto Y, Nagata S. The polypeptide encoded by the cDNA for human cell surface antigen Fas can mediate apoptosis. Cell 1991; 66: 233–243
   PubMed Web of Science ®Google Scholar
• Desbarats J, Birge RB, Mimouni-Rongy M, Weinstein DE, Palerme JS, Newell MK. Fas engagement induces neurite growth through ERK activation and P53 upregulation. Nature Cell Biology 2003; 5: 118–125
   PubMed Web of Science ®Google Scholar